Milestone’s etripamil nasal spray enters Phase III trial for atrial fibrillation
Executive Overview In a significant milestone for cardiovascular therapeutics, Milestone Pharmaceuticals has officially announced the dosing of the first patient...
Executive Overview In a significant milestone for cardiovascular therapeutics, Milestone Pharmaceuticals has officially announced the dosing of the first patient...